Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 113 results.
User Information
Export Records
  1. 1.   Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
  2. Joyce, M Gordon; Bu, Wei; Chen, Wei-Hung; Gillespie, Rebecca A; Andrews, Sarah F; Wheatley, Adam K; Tsybovsky,Yaroslav; Jensen, Jaime L; Stephens,Tyler; Prabhakaran, Madhu; Fisher, Brian E; Narpala, Sandeep R; Bagchi, Meghna; McDermott, Adrian B; Nabel, Gary J; Kwong, Peter D; Mascola, John R; Cohen, Jeffrey I; Kanekiyo, Masaru
  3. Immunity. 2025, Feb 11; 58(2): 295-308.e5. .
  1. 2.   Immunization of Mice with Virus-Like Vesicles of Kaposi Sarcoma-Associated Herpesvirus Reveals a Role for Antibodies Targeting ORF4 in Activating Complement-Mediated Neutralization
  2. Lam, Alex K; Roshan,Romin; Miley,Wendell; Labo, Nazzarena; Zhen, James; Kurland, Andrew P; Cheng, Celine; Huang, Haigen; Teng, Pu-Lin; Harelson, Claire; Gong, Danyang; Tam, Ying K; Radu, Caius G; Epeldegui, Marta; Johnson, Jeffrey R; Zhou, Z Hong; Whitby,Denise; Wu, Ting-Ting
  3. Journal of Virology. 2023, Feb 09; e0160022.
  1. 3.   Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients
  2. Lage, Silvia Lucena; Rocco, Joseph M; Laidlaw, Elizabeth; Rupert,Adam; Galindo, Frances; Kellogg,Anela; Kumar, Princy; Poon, Rita; Wortmann, Glenn W; Lisco, Andrea; Manion, Maura; Sereti, Irini
  3. Frontiers in Immunology. 2022, Feb 17; 13: 815833.
  1. 4.   The Complement Pathway Is Activated in People With Human Immunodeficiency Virus and Is Associated With Non-AIDS Comorbidities
  2. Vujkovic-Cvijin, Ivan; Sortino,Ornella; Verheij, Eveline; Wit, Ferdinand W.; Kootstra, Neeltje A.; Sellers, Brian; van der Loeff, Maarten Schim; Belkaid, Yasmine; Reiss, Peter; Sereti, Irini
  3. Journal of Infectious Diseases. 2021, Oct 28; 224(8): 1405-1409.
  1. 5.   Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm
  2. Kozma, Gergely Tibor; Mészáros, Tamás; Bakos, Tamás; Hennies, Mark; Bencze, Dániel; Uzonyi, Barbara; Gyorffy, Balázs; Cedrone,Edward; Dobrovolskaia,Marina; Józsi, Mihály; Szebeni, János
  3. Frontiers in Immunology. 2021, Apr 28; 12: 642860.
  1. 6.   Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1
  2. Sung, Heejong; Hyland, Paula L; Pemov, Alexander; Sabourin, Jeremy A; Baldwin, Andrea M; Bass,Sara; Teshome,Kedest; Luo,Wen; Widemann, Brigitte C; Stewart, Douglas R; Wilson, Alexander F
  3. Molecular genetics & genomic medicine. 2020, Aug 31; e1400.
  1. 7.   One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility
  2. Mohammadpour, Raziye; Cheney, Darwin L; Grunberger, Jason W; Yazdimamaghani, Mostafa; Jedrzkiewicz, Jolanta; Isaacson, Kyle J; Dobrovolskaia,Marina; Ghandehari, Hamidreza
  3. Journal of controlled release : official journal of the Controlled Release Society. 2020, AUG 10; 324: 471-481.
  1. 8.   PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies
  2. Bavli, Yaelle; Chen, Bing-Mae; Roffler, Steve R; Dobrovolskaia,Marina; Elnekave, Eldad; Ash, Shifra; Barenholz, Yechezkel; Turjeman, Keren
  3. Molecules (Basel, Switzerland). 2020, Jan 28; 25(3): pii: molecules25030558.
  1. 9.   RNA2Drawer: Geometrically Strict Drawing of Nucleic Acid Structures with Graphical Structure Editing and Highlighting of Complementary Subsequences
  2. Johnson, Philip Z; Kasprzak,Wojciech; Shapiro,Bruce; Simon, Anne E
  3. RNA biology. 2019, Aug 26; 1-5.
  1. 10.   Nanoparticle physicochemical properties determine the activation of intracellular complement
  2. Ilinskaya, Anna N.; Shah, Ankit; Enciso, Alan E.; Chan,King; Kaczmarczyk,Jan; Blonder,Josip; Simanek, Eric E.; Dobrovolskaia,Marina
  3. Nanomedicine : nanotechnology, biology, and medicine. 2019, APR; 17: 266-275.
  1. 11.   Blood Interactions, Pharmacokinetics, and Depth-Dependent Ablation of Rat Mammary Tumors with Photoactivatable, Liposomal Doxorubicin
  2. Carter, Kevin A.; Luo, Dandan; Geng, Jumin; Stern, Steve; Lovell, Jonathan F.
  3. Molecular cancer therapeutics. 2019, Mar; 18(3): 592-601.
  1. 12.   Roadmap and strategy for overcoming infusion reactions to nanomedicines
  2. Szebeni, Janos; Simberg, Dmitri; Gonzalez-Fernandez, Africa; Barenholz, Yechezkel; Dobrovolskaia,Marina
  3. Nature nanotechnology. 2018, Dec; 13(12): 1100-1108.
  1. 13.   Single-cell RNA sequencing of the mammalian pineal gland identifies two pinealocyte subtypes and cell type-specific daily patterns of gene expression
  2. Mays, Joseph C.; Kelly, Michael; Coon, Steven L.; Holtzclaw, Lynne; Rath, Martin F.; Kelley, Matthew W.; Klein, David C.
  3. PLOS ONE. 2018, Oct 22; 13(10):
  1. 14.   Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
  2. Neun, Barry; Barenholz, Yechezkel; Szebeni, Janos; Dobrovolskaia, Marina
  3. Molecules. 2018, Jul 12; 23(7): pii: E1700.
  1. 15.   Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations
  2. Zamboni, William C.; Szebeni, Janos; Kozlov, Serguei; Lucas, Andrew T.; Piscitelli, Joseph A.; Dobrovolskaia, Marina
  3. Advanced drug delivery reviews. 2018, Nov-Dec; 136: 82-96.
  1. 16.   Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations
  2. Cedrone, Edward; Neun, Barry; Rodriguez, Jamie; Vermilya, Alison; Clogston, Jeffrey; McNeil, Scott; Barenholz, Yechezkel; Szebeni, Janos; Dobrovolskaia, Marina
  3. Molecules . 2018, Jan; 23(1): pii: E12.
  1. 17.   Analytical characterization of ch14.18 A mouse-human chimeric disialoganglioside-specific therapeutic antibody
  2. Soman, G.; Kallarakal, A. T.; Michiel, D.; Yang, X. Y.; Saptharishi, N.; Jiang, H. G.; Giardina, S.; Gilly, J.; Mitra, G.
  3. Mabs. 2012, Jan-Feb; 4(1): 84-100.
  1. 18.   Evidence of association of APOE with age-related macular degeneration - a pooled analysis of 15 studies
  2. McKay, G. J.; Patterson, C. C.; Chakravarthy, U.; Dasari, S.; Klaver, C. C.; Vingerling, J. R.; Ho, L.; de Jong, P.; Fletcher, A. E.; Young, I. S.; Sel, J. H.; Rahu, M.; Soubrane, G.; Tomazzoli, L.; Topouzis, F.; Vioque, J.; Hingorani, A. D.; Sofat, R.; Dean, M.; Sawitzke, J.; Seddon, J. M.; Peter, I.; Webster, A. R.; Moore, A. T.; Yates, J. R. W.; Cipriani, V.; Fritsche, L. G.; Weber, B. H. F.; Keilhauer, C. N.; Lotery, A. J.; Ennis, S.; Klein, M. L.; Francis, P. J.; Stambolian, D.; Orlin, A.; Gorin, M. B.; Weeks, D. E.; Kuo, C. L.; Swaroop, A.; Othman, M.; Kanda, A.; Chen, W.; Abecasis, G. R.; Wright, A. F.; Hayward, C.; Baird, P. N.; Guymer, R. H.; Attia, J.; Thakkinstian, A.; Silvestri, G.
  3. Human Mutation. 2011, Dec; 32(12): 1407-1416.
  1. 19.   Association Assessment of Copy Number Polymorphism and Risk of Age-Related Macular Degeneration
  2. Sawitzke, J.; Im, K. M.; Kostiha, B.; Dean, M.; Gold, B.
  3. Ophthalmology. 2011, Dec; 118(12): 2442-2446.
  1. 20.   Foamy Retrovirus Integrase Contains a Pol Dimerization Domain Required for Protease Activation
  2. Lee, E. G.; Roy, J.; Jackson, D.; Clark, P.; Boyer, P. L.; Hughes, S. H.; Linial, M. L.
  3. Journal of Virology. 2011, Feb; 85(4): 1655-1661.
  1. 21.   The ERCC6 Gene and Age-Related Macular Degeneration
  2. Baas, D. C.; Despriet, D. D.; Gorgels, T.; Bergeron-Sawitzke, J.; Uitterlinden, A. G.; Hofman, A.; van Duijn, C. M.; Merriam, J. E.; Smith, R. T.; Barile, G. R.; ten Brink, J. B.; Vingerling, J. R.; Klaver, C. C. W.; Allikmets, R.; Dean, M.; Bergen, A. A. B.
  3. Plos One. 2010, Nov; 5(11): 9.
  1. 22.   Minireview: Nanoparticles and the Immune System
  2. Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A.
  3. Endocrinology. 2010, Feb; 151(2): 458-465.
  1. 23.   Multilocus analysis of age-related macular degeneration
  2. Bergeron-Sawitzke, J.; Gold, B.; Olsh, A.; Schlotterbeck, S.; Lemon, K.; Visvanathan, K.; Allikmets, R.; Dean, M.
  3. European Journal of Human Genetics. 2009 17(9): 1190-1199.
  1. 24.   Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles
  2. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J. W.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2009 5(2): 106-117.
  1. 25.   Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
  2. Friew, Y. N.; Boyko, V.; Hu, W. S.; Pathak, V. K.
  3. Retrovirology. 2009 6 AR 56
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel